ReviewTherapeutic advances in medical oncology2015
Combination capecitabine and bevacizumab in the treatment of metastatic hepatic epithelioid hemangioendothelioma.
Review in Therapeutic advances in medical oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 35 citations in OpenAlex.
- Pulsed ultrasound-stimulated microbubbles alter the tumor blood supply to enhance the efficacy of high-intensity focused ultrasound ablation of vascular tumors.Frontiers in oncology · 2026Article
- Hepatic epithelioid hemangioendothelioma managed with minimally invasive surgery: A case report.World journal of clinical cases · 2025Article
- Hepatic epithelioid hemangioendothelioma, a rare liver tumor: a case report and review of the literature.Frontiers in oncology · 2025Article
- The challenges of hepatic epithelioid hemangioendothelioma: the diagnosis and current treatments of a problematic tumor.Orphanet journal of rare diseases · 2024Review
- Dual immunotherapy alternating with anti-PD-1 antibody plus liposomal doxorubicin show good efficacy in prostate epithelioid hemangioendothelioma: a case report.Frontiers in immunology · 2024Article
- Comprehensive evaluation of clinical outcomes in hepatic epithelioid hemangioendothelioma subsets: insights from SEER Database and departmental cohort analysis.Frontiers in immunology · 2024Article
- Article
- Can angiogenesis inhibitor therapy cause changes in imaging features of hepatic hemangioma- Initial study.Frontiers in oncology · 2023Article
- Hepatic epithelioid hemangioendothelioma-a single-institution experience with 51 cases.Frontiers in oncology · 2023Article
- Hepatic epithelioid hemangioendothelioma after thirteen years' follow-up: A case report and review of literature.World journal of clinical cases · 2022Article
- Advanced epithelioid hemangioendothelioma of the liver: could lenvatinib offer a bridge treatment to liver transplantation?Therapeutic advances in medical oncology · 2022Article
- Treatment and Prognosis of Hepatic Epithelioid Hemangioendothelioma: A SEER Database Analysis.World journal of surgery · 2021Article
- Laparoscopic resection of hepatic epithelioid hemangioendothelioma: report of eleven rare cases and literature review.World journal of surgical oncology · 2020Review
- Hepatic epithelioid hemangioendothelioma: Update on diagnosis and therapy.World journal of clinical cases · 2020Review
- Hepatic Hemangioendothelioma: An update.World journal of gastrointestinal oncology · 2020Review
- Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma.Cancers · 2018Review
- Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment.Current treatment options in oncology · 2018Review
- Suprasellar epithelioid hemangioendothelioma: Case report and review of the literature.Surgical neurology international · 2016Article
- Hepatic Epithelioid Hemangioendothelioma - a Rare Tumor and Diagnostic Dilemma.In vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatic epithelioid hemangioendothelioma (HEHE) is a rare, often misdiagnosed vascular neoplasm with clinical behaviors that range from indolent to highly aggressive. Even when the appropriate diagnosis is achieved, the best treatment for HEHE has not been defined or standardized, further complicating the care of these patients. We present a diagnostically challenging case of HEHE where we utilized capecitabine and bevacizumab as another novel treatment option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.